Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Leist TP, Comi G, Cree BAC, Coyle PK, Freedman MS, Hartung H-P, Vermersch P, Casset-Semanaz F, Scaramozza M, oral cladribine for early MS(ORACLE MS) Study Group